Thermo Fisher Scientific Specialty Diagnostics — Purchases of property, plant and equipment increased by 30.8% to $34.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 30.8%, from $26.00M to $34.00M.
Higher spending suggests aggressive growth or maintenance investment, whereas lower spending may indicate a focus on cash flow preservation or completed infrastructure cycles.
This metric measures the cash outflows for capital expenditures related to property, plant, and equipment within the Spe...
Standard capital expenditure (CapEx) metric found in segment reporting across the medical device and diagnostics industry.
tmo_segment_specialty_diagnostics_purchases_of_property_plant_and_equipment| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q3 '25 | |
|---|---|---|---|---|---|---|
| Value | $30.25M | $30.25M | $30.25M | $30.25M | $26.00M | $34.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -14.0% | +30.8% |
| YoY Change | — | — | — | — | -14.0% | +30.8% |
We use cookies for analytics. See our Privacy and Cookie Policy.